Marcello Casaccia Bertoluci, Wellington S Silva Júnior, Fernando Valente, Levimar Rocha Araujo, Ruy Lyra, João Jácome de Castro, João Filipe Raposo, Paulo Augusto Carvalho Miranda, Cesar Luiz Boguszewski, Alexandre Hohl, Rui Duarte, João Eduardo Nunes Salles, José Silva-Nunes, Jorge Dores, Miguel Melo, João Roberto de Sá, João Sérgio Neves, Rodrigo Oliveira Moreira, Marcus Vinícius Bolívar Malachias, Rodrigo Nunes Lamounier, Domingos Augusto Malerbi, Luis Eduardo Calliari, Luis Miguel Cardoso, Maria Raquel Carvalho, Hélder José Ferreira, Rita Nortadas, Fábio Rogério Trujilho, Cristiane Bauermann Leitão, José Augusto Rodrigues Simões, Mónica Isabel Natal Dos Reis, Pedro Melo, Mafalda Marcelino, Davide Carvalho
BACKGROUND: The management of antidiabetic therapy in people with type 2 diabetes (T2D) has evolved beyond glycemic control. In this context, Brazil and Portugal defined a joint panel of four leading diabetes societies to update the guideline published in 2020. METHODS: The panelists searched MEDLINE (via PubMed) for the best evidence from clinical studies on treating T2D and its cardiorenal complications. The panel searched for evidence on antidiabetic therapy in people with T2D without cardiorenal disease and in patients with T2D and atherosclerotic cardiovascular disease (ASCVD), heart failure (HF), or diabetic kidney disease (DKD)...
July 19, 2023: Diabetology & Metabolic Syndrome